Both PROX1 and SLC30A8, together with other T2D risk loci (IL6R, TCF7L2, HNF1A) and 21 genes reported as associated with plasma lipids in humans [22] were predicted as target genes of NCOA2 in our study. This evidence concerns the gene IL6R and type 2 diabetes mellitus.